Life Technologies | Driftsresultatet



Operating Profit Endring Dato
Ardelyx USD 8.12M 5.89M 2024-12
Biogen USD 441.4M 24.4M 2024-12
Bristol-Myers Squibb USD 793M 1.39B 2024-12
Cipla INR 17.09B 952.7M 2024-12
Clal Biotechnology ILS -1738000 7.46M 2022-12
Compugen USD -7483000 11.98M 2024-12
CSL USD 1.2B 1.41B 2024-06
Galapagos EUR -62720000 8.41M 2024-12
GlaxoSmithKline GBP 696M 507M 2024-12
Grifols EUR 371.86M 54.83M 2024-12
Life Technologies USD -15820000 2.32M 2024-12
Novartis USD 2.28B 1.34B 2024-12
Roche Holding CHF 4.39B 1.04B 2024-12
United Therapeutics USD 357.7M 14.6M 2024-12



Life Technologies Driftsresultatet - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Apr 2025.